Wolverine Asset Management’s Aegerion Pharmaceuticals AEGR Stock Holding History

Wolverine Asset Management’s Portfolio AEGR Stock Details AEGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-42	Closed	-$1K	–	2099
2015 Q2	$1K	Hold	42	–	–	﹤0.01%	1823
2015 Q1	$6K	Hold	42	–	–	﹤0.01%	1625
2014 Q4	$10K	Hold	42	–	–	﹤0.01%	1761
2014 Q3	$18K	Hold	42	–	–	﹤0.01%	1848
2014 Q2	$18K	Buy	+42	New	+$1.56K	﹤0.01%	1722
2014 Q1	–	Sell	-390	Closed	-$393K	–	2992
2013 Q4	$393K	Buy	+390	New	+$29.8K	0.01%	866

Wolverine Asset Management's AEGR Position: Q4 2016 in Review

Wolverine Asset Management sold out of Aegerion Pharmaceuticals (AEGR) in Q4 2016, closing a stake of 13,354 shares — an estimated $39K sold.

Wolverine Asset Management first reported a position in AEGR in Q2 2016 and held it in 2 quarters. The position peaked at $39K in Q3 2016. 0 funds tracked by Wall St. Rank hold AEGR as of Q4 2016.

Wolverine Asset Management reported no remaining Aegerion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
Wolverine Asset Management sold 13,354 Aegerion Pharmaceuticals shares in Q4 2016, an estimated $39K.
Wolverine Asset Management first reported a position in Aegerion Pharmaceuticals in Q2 2016 and held it in 2 quarters.
Wolverine Asset Management's Aegerion Pharmaceuticals position peaked at $39K in Q3 2016.
0 funds tracked by Wall St. Rank held Aegerion Pharmaceuticals as of Q4 2016.

Based on Wolverine Asset Management's 13F filing for Q4 2016, filed 13 Feb 2017.